OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
Rhea-AI Summary
OraSure Technologies (NASDAQ: OSUR) has scheduled its second quarter 2025 earnings conference call for August 5, 2025, at 5:00 PM ET. The company will discuss Q2 2025 financial results and business developments during the call.
Investors can access the webcast through OraSure's investor relations website. The webcast will be archived and available for approximately one year after the call. Participants who wish to ask questions during the call must pre-register through the provided link to receive access details.
Positive
- None.
Negative
- None.
News Market Reaction 8 Alerts
On the day this news was published, OSUR gained 6.15%, reflecting a notable positive market reaction. Argus tracked a peak move of +2.4% during that session. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $15M to the company's valuation, bringing the market cap to $259M at that time.
Data tracked by StockTitan Argus on the day of publication.
BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business developments for 5 p.m. ET on August 5, 2025.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately one year.
For participants interested in asking questions during the conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.
https://register-conf.media-server.com/register/BIdfa47088da4a422f967ac3a63ee20f09
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure” and “OTI”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OTI improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., OTI is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OTI’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information, please visit www.orasure.com
| Investor Contact: Jason Plagman VP, Investor Relations investorinfo@orasure.com | Media Contact: Amy Koch Director, Corporate Communications media@orasure.com |
FAQ
When is OraSure Technologies (OSUR) reporting Q2 2025 earnings?
How can I access OraSure's Q2 2025 earnings call?
How long will OraSure's Q2 2025 earnings call webcast be available?
How can investors ask questions during OraSure's Q2 earnings call?
